Publication announced

Publication announced

A technical paper on the Clinical Trial Risk Tool has been published in Gates Open Research!

The Clinical Trial Risk Tool is a browser-based tool which uses Natural Language Processing (NLP) to analyse clinical trial protocols. We are pleased to announce the publication of a technical paper on the tool.

  • Wood TA and McNair D. Clinical Trial Risk Tool: software application using natural language processing to identify the risk of trial uninformativeness [version 1; peer review: 1 approved with reservations]. Gates Open Res 2023, 7:56 doi.org/10.12688/gatesopenres.14416.1

Open access natural language processing paper

Read Gates Open Research paper

Our publication is open access. Click to read online or download as PDF.

A BibTex citation is as follows:

@article{wood2023clinical,
  title={Clinical Trial Risk Tool: software application using natural language processing to identify the risk of trial uninformativeness},
  author={Wood, Thomas A and McNair, Douglas},
  journal={Gates Open Research},
  volume={7},
  number={56},
  pages={56},
  year={2023},
  publisher={F1000 Research Limited}
}

Clinical Trial Designs

Clinical Trial Designs

Clinical trial designs vary considerably, impacting study execution, patient recruitment, endpoints, and treatment delivery. Here’s a brief summary of some common designs: First-In-Human (FIH) Studies These are the initial human trials for a new drug, procedure, or treatment, focusing primarily on safety. Cohort Studies These observational studies follow a group of individuals over an extended period to assess risk factors associated with developing specific conditions. Case-Control Studies These studies compare individuals with a particular disease or condition (cases) to similar individuals without the disease (controls) to identify potential risk factors.

How AI-Driven Tools are Transforming Risk Assessment and Cost Estimation

How AI-Driven Tools are Transforming Risk Assessment and Cost Estimation

This post originally appeared on Fast Data Science’s blog on LinkedIn. The Growing Role of AI in Clinical Trials Clinical trials are vital for advancing medicine, but managing them efficiently is a constant challenge. Traditional methods for assessing risks and estimating costs often miss the mark, leading to delays and unexpected expenses. This is where Artificial Intelligence (AI) and Natural Language Processing (NLP) come into play, offering smarter, data-driven solutions to streamline trial planning and management.

Tips for Creating an Effective Clinical Research Budget

Tips for Creating an Effective Clinical Research Budget

This post originally appeared on Fast Data Science’s blog on LinkedIn. Budgeting is one of the most critical steps when planning a clinical trial. Clinical trials are complex, multi-phase studies that require significant resources, and understanding the costs associated with each phase is crucial for an accurate clinical trial budget. In this post, we’ll explore the different phases of clinical trials and the key factors that influence their costs, providing insights into how to prepare a comprehensive budget that aligns with your trial’s needs.